Alzheimer's Association awards $4.3 million to accelerate the launch of new drug treatment
The Alzheimer's Association has awarded $4.3 million to accelerate the testing of new potential therapies and diagnostic approaches for Alzheimer's disease. The funding will support innovative trial designs, including tau PET imaging and home-based cognitive testing, to improve early detection and treatment options.